Gamma-Aminobutyric Acid

Gamma-Aminobutyric Acid

SCHEMBL5574736

NCCCC(=O)O.O=[N+]([O-])c1cccc2nonc12

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 10/20 0.44
GSTM2 P28161 10/20 0.44
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
MYC P01106 3/20 0.40
USP2 O75604 2/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
IDO1 P14902 2/20 0.39
TXNRD1 Q16881 1/20 0.39
TXNRD3 Q86VQ6 1/20 0.39
TXNRD2 Q9NNW7 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93759 0.81 TXNRD1 (0.54) GSTP1GSTM2MEN1KMT2AMYC
Hydrogen Sulfide SCHEMBL16111783 0.80 TXNRD1 (0.53) GSTP1GSTM2MEN1KMT2AMYC
Hydrochloric Acid SCHEMBL3785878 0.80 TXNRD1 (0.53) GSTP1GSTM2MEN1KMT2AMYC
Pyridine SCHEMBL26106735 0.76 TXNRD1 (0.46) GSTP1GSTM2MEN1KMT2AMYC
Norleucine SCHEMBL28902593 0.76 GRM8 (0.43) MEN1KMT2AMYCRECQLALDH1A1
SCHEMBL7332645 0.74 MEN1 (0.37) GSTP1GSTM2MEN1KMT2AMYC
Aminocaproic Acid SCHEMBL29028429 0.71 MEN1 (0.41) MEN1KMT2ARECQLALDH1A1CYP2D6
SCHEMBL7714790 0.70 GSTP1 (0.54) GSTP1GSTM2MEN1KMT2AMYC
SCHEMBL6759398 0.69 TXNRD1 (0.42) GSTP1GSTM2MEN1KMT2AMYC
SCHEMBL14617994 0.69 GSTM2 (0.72) GSTP1GSTM2MEN1KMT2AMYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7172877-B2 Methods and compositions for peptide and protein labeling MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-02-06 US disclosed
US-20050233389-A1 Methods and compositions for peptide and protein labeling MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2005-10-20 US disclosed
US-20040209317-A1 Methods and compositions for peptide and protein labeling MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050233389-A1 Methods and compositions for peptide and protein labeling HLCS, BTD, QPCTL GSTP1 3394/4885GSTM2 4223/4885MEN1 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.